106 filings
Page 4 of 6
8-K
tyy1h2f vc
10 Nov 22
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update
7:12am
8-K
q749 8om9zno92
20 Oct 22
Talaris Therapeutics Provides Update on FREEDOM-1 Phase 3 Clinical Trial
7:12am
EFFECT
zsce ym9cdv
26 Aug 22
Notice of effectiveness
12:15am
CORRESP
aogs640 87tn
23 Aug 22
Correspondence with SEC
12:00am
UPLOAD
ln8kkm
22 Aug 22
Letter from SEC
12:00am
S-3
ar4sp5ez0xyf vi
15 Aug 22
Shelf registration
5:06pm
8-K
rpvi kf71f2lkdizdk
15 Aug 22
Talaris Therapeutics Announces Second Quarter Financial Results and Corporate Update
7:13am
8-K
sljns93jdld ra
30 Jun 22
Other Events
4:54pm
8-K
jr8 maaax3rc
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
3hbwuvmz
17 May 22
Talaris Therapeutics Announces Changes to Board of Directors
8:29am
8-K
bes9klgnui9g3n0m8
12 May 22
Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update
4:07pm
DEFA14A
k973zrl ili6zy
29 Apr 22
Additional proxy soliciting materials
4:27pm
DEF 14A
ulz8xub9ndocsjeix
29 Apr 22
Definitive proxy
4:24pm
S-8
egv67lp95x23
17 Mar 22
Registration of securities for employees
4:41pm
10-K
pyic5z2378k45o
17 Mar 22
Annual report
4:31pm
8-K
twjjes
17 Mar 22
Talaris Therapeutics Announces Fourth Quarter and Year-End Financial Results and Provides Business Update
4:13pm